Clinical Trials Offering Hope To Ovarian Cancer Families
Recently there has been a lot in the news about the “Big C” (cancer) and various developments taking place in medical research. One of the most insidious things about this particular disease is that it affects everyone – directly and indirectly and ovarian cancer is no exception.Ovarian cancer is the fourth most frequently diagnosed cancer, according to the WHC (is the second leading cause of death due to gynaecological malignancies in the world ) – translating into a devastating number of women and their families lives being affected by this life-threatening illness.
Women diagnosed with the disease have a 15 per cent chance of surviving beyond the first five years if the cancer is diagnosed at an advanced stage. The five-year survival rate is 80 per cent if the cancer is detected early however a study suggests that “women with ovarian cancer are dying because GPs are failing to detect the early signs of the disease”. One very simple fact that highlights the necessity for medical research and development of a cure.
In my research of the subject, I noted one such company working on a treatment cure are Biocancell, which develops ovarian and bladder cancer treatments based on the use of H19 gene. Interestingly, the first cancer treatment utilizing H19, designated BC-819, works to destroy cancerous cells only. BC-819 is in the clinical trial stage for treatment of ovarian cancer, pancreatic cancer and superficial bladder cancer. It has also been tested in compassionate use trials for liver cancer and kidney TCC. Clinical results have shown effectiveness in removing existing cancerous growths and keeping patients clear of new growths.
Ovarian and bladder cancer clinical trials are recruiting for BioCancell’s OVARIAN CANCER first treatment, BC-819. To be eligible to participate in this study, patients must meet a number of inclusion/exclusion criteria. For more information fill the information request form. Continue to check this website as trial information and locations are being updated periodically.
